Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.150
+0.020 (0.94%)
At close: Dec 26, 2024, 4:00 PM
2.180
+0.030 (1.40%)
Pre-market: Dec 27, 2024, 9:04 AM EST

Tharimmune Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
5.825.94.61.370.670.63
Research & Development
5.33.562.281.840.850.37
Operating Expenses
11.129.466.883.211.520.99
Operating Income
-11.12-9.46-6.88-3.21-1.52-0.99
Interest Expense
-0.01-0.02-1.59-0.83-0.25-0.08
Interest & Investment Income
0.280.15----
EBT Excluding Unusual Items
-10.85-9.32-8.47-4.04-1.77-1.07
Other Unusual Items
---1.83-0.36-0.03
Pretax Income
-10.85-9.32-8.47-2.21-2.42-1.53
Net Income
-10.85-9.32-8.47-2.21-2.42-1.53
Net Income to Common
-10.85-9.32-8.47-2.21-2.42-1.53
Shares Outstanding (Basic)
100000
Shares Outstanding (Diluted)
100000
Shares Change (YoY)
2357.50%188.38%78.02%0.16%54.28%-
EPS (Basic)
-11.95-107.08-280.76-130.16-142.82-139.05
EPS (Diluted)
-11.95-107.08-280.76-130.16-142.82-139.05
Free Cash Flow
-9.28-7.3-6.56-1.09-1.08-0.71
Free Cash Flow Per Share
-10.23-83.88-217.30-64.07-63.71-64.36
EBIT
-11.12-9.46-6.88-3.21-1.52-0.99
Source: S&P Capital IQ. Standard template. Financial Sources.